Search for the Holy Grail: Diabetes Clinical Study to Commence Next Month
The search is over! . . . well, almost. Researchers at Mount Sinai are conducting a study next month that could stop the progress of type-2 diabetes in its early stages. According to recent news, “data collected from patient studies by [Dr. Ravi Retnakaran] and Dr. Caroline Kramer found short-term insulin therapy for two or three weeks can restore the body’s ability to make and use insulin. If all goes to plan, diabetes management (and future research at that) could change dramatically and shed light on insulin and insulin production. The Body and Insulin Production:
- The beta-cells in the pancreas, which produces insulin, are almost always damaged beyond repair by the time insulin therapy is prescribed.
- Because of the damage, medications are prescribed, usually one at a time, until insulin becomes a permanent need.
- This new insulin treatment study could catch type-2 diabetes in its early stages, making it easier for natural insulin production.
- If the study is successful it will be preventative in terms of preventing the deterioration of the beta cells.